跳至主要内容
临床试验/NL-OMON39418
NL-OMON39418已完成不适用

Repeated measurements in patients presenting with ST-segment elevation myocardial infarction of Advanced Glycation Endproducts by skin autofluorescence and serum analysis: a pilot study. - STAGE study

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Men and women, aged from 18 year, capable of understanding the study content of and willing to provide written informed consent at admission to the hospital.
  • - Diagnosis of STEMI, according to the guidelines of the European Society of Cardiology (ESC) 2008. The diagnosis is defined as a history of chest pain / discomfort lasting for
  • 10 - 20 minutes or more (not responding fully to nitroglycerine) with persistent ST segment elevation and elevated markers of myocardial necrosis. Other causes of chest pain / discomfort must be ruled out by the cardiologist.
  • - Symptom duration <6h.

排除标准

  • - Admission for an ACS <6 months
  • - Clinically significant renal disturbance (GFR (MDRD) <= 30 mL/min/1.73m2) or known renal disease
  • - Severe inflammatory or current malignant disease
  • - Darkly coloured skin
  • - Auto-immune / connective tissue disease
  • - Aorta dissection
  • - Comatose at admission to the CCU

研究者

相似试验

Repeated measurements in patients presenting with... | 临床试验